Rx/Reimbursement adult incontinence

Market research on the tissue and hygiene industry. Our reports f...

Market research on the tissue and hygiene industry. Our reports feature standardised and cross-comparable total market sizes, market and brand share data, distribution and trends.​​

 
Country Report

Rx/Reimbursement Adult Incontinence in Kazakhstan

May 2022

Rx sales of adult incontinence continue to show strong growth in Kazakhstan in 2021. This primarily reflects the increase in average age of the population, as well as the fact that older consumers have been the most likely to be admitted to hospital…

USD 1,195
Country Report

Rx/Reimbursement Adult Incontinence in Denmark

Apr 2022

The ongoing ageing of Denmark’s population continued to drive rising consumption, given that the elderly is the group most likely to experience incontinence. In addition, high obesity rates are also a factor driving value growth.

USD 1,195
Country Report

Rx/Reimbursement Adult Incontinence in Italy

Mar 2022

RX/reimbursement adult incontinence continued to decline in Italy in 2021 as a consequence of the spending review of the regional branches of the National Sanitary System. The Italian reimbursement scheme is an integral part of welfare assistance,…

USD 1,195
Country Report

Rx/Reimbursement Adult Incontinence in Poland

May 2022

RX/reimbursement adult incontinence is a more substantial category in Poland than retail adult incontinence and has continued to record stable demand during the pandemic. This was supported by an ageing population (with more older adults identifying…

USD 1,195
Country Report

Rx/Reimbursement Adult Incontinence in Croatia

May 2022

In 2021, there were no changes to the regulatory frame regarding the number of incontinence products, per person, per year, that are covered by HZZO (Croatian medical system). Rules on subsidies are clearly stated in a legal guideline, which states…

USD 1,195
Country Report

Rx/Reimbursement Adult Incontinence in Israel

Apr 2022

Sales of Rx/reimbursement adult incontinence products continued to see solid volume growth in 2021, along with a slightly higher current value increase due to price rises. Like other hygiene categories, COVID-19 had little impact on the growth rates,…

USD 1,195
Country Report

Rx/Reimbursement Adult Incontinence in Norway

May 2022

Coronavirus (COVID-19) was deemed to have had a limited impact on Rx/reimbursement adult incontinence in Norway. This was mainly because these products are prescribed. Therefore, lockdown and home seclusion, the rising preventive health trend and…

USD 1,195
Country Report

Rx/Reimbursement Adult Incontinence in Lithuania

May 2022

Erosion of taboos and increasing consumer awareness benefit the product area

USD 1,195
Country Report

Rx/Reimbursement Adult Incontinence in Estonia

May 2022

The pandemic did not have a major impact on Rx/reimbursement adult incontinence, as the product is essential, and in 2021, it registered healthy current value and volume growth. Moderate/heavy adult incontinence products performed better than light,…

USD 1,195
Country Report

Rx/Reimbursement Adult Incontinence in Malaysia

Mar 2022

There is no presence of Rx/reimbursement adult incontinence in Malaysia in 2021 and no indication that this will change in the forecast period.

USD 1,195
Country Report

Rx/Reimbursement Adult Incontinence in the US

Mar 2022

Heightened health awareness, the expanding consumer base for incontinence products, as well as pandemic-induced rising enrolment in Medicaid, a critical safety net for a vast vulnerable population during economic downturns, continued to drive…

USD 1,195
Country Report

Rx/Reimbursement Adult Incontinence in Australia

Mar 2022

Rx/reimbursement incontinence in Australia is administered through the Continence Aids Payment Scheme (CAPS) offered by the Australian government. This is a non-taxable payment paid either annually or twice a year to cover some of the costs of…

USD 1,195
Country Report

Rx/Reimbursement Adult Incontinence in Slovenia

May 2022

Rx/reimbursement adult incontinence registered both current value and volume growth in 2021. However, growth was lower than in 2020, as hospitals treated less older patients with COVID-19, who also suffered from incontinence issues. The Institute of…

USD 1,195
Country Report

Rx/Reimbursement Adult Incontinence in Slovakia

May 2022

Value sales of Rx/reimbursement adult incontinence have seen slightly slower growth since the outbreak of COVID-19, with the pandemic creating some short-term disruptions to access, with some consumers facing difficulty accessing healthcare…

USD 1,195
Country Report

Rx/Reimbursement Adult Incontinence in Hungary

May 2022

Hungary’s ageing population provided opportunity for further category growth in 2021. The majority of people with incontinence visit the doctor only when the problem is quite severe, which means that education is important in terms of how they may…

USD 1,195
Country Report

Rx/Reimbursement Adult Incontinence in Portugal

May 2022

USD 1,195
Country Report

Rx/Reimbursement Adult Incontinence in Sweden

May 2022

The fact that Rx/reimbursement adult incontinence products are available free of charge through Sweden’s public healthcare system and generally considered necessities by those who use them has helped to shield this category from the fallout of the…

USD 1,195
Country Report

Rx/Reimbursement Adult Incontinence in Latvia

May 2022

Rx/reimbursement adult incontinence was largely unaffected by the pandemic, as it is an essential product. In 2021, volume growth was on par with 2020, though value growth was higher, due to price rises. Moderate/heavy adult incontinence products…

USD 1,195
Country Report

Rx/Reimbursement Adult Incontinence in Switzerland

May 2022

With consumer behaviour returning to normal again in 2021, Rx/reimbursement incontinence recorded stronger growth. Being more active and away from home increased the need for incontinence products overall. Additionally, more consumers were willing to…

USD 1,195
Country Report

Rx/Reimbursement Adult Incontinence in Belgium

May 2022

Rx/reimbursement adult incontinence recorded an upturn in demand over the course of 2021, driven by increasing price sensitivity as consumers looked to save money wherever possible, in addition to greater awareness of their entitlement to these…

USD 1,195
Passport Our solution covers your every research need, providing context around your business for a deeper market view. Learn More